RT Book, Section A1 Park, Jamie A1 Chan, Samuel SR Print(0) ID 1190798972 T1 Pembrolizumab did not show overall survival benefit in patients with microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer T2 2 Minute Medicine YR 2015 FD 2015 PB McGraw Hill PP New York, NY SN LK accessmedicine.mhmedical.com/updatesContent.aspx?gbosid=582964 RD 2024/03/28 AB